Melbourne, Australia
Smileyscope, an innovative player in the Health Care industry, has emerged as a pioneer in utilizing virtual reality technology to enhance medical experiences. Founded in 2017 and headquartered in Australia, the company’s mantra, “Improving needle experiences through innovative virtual reality technology,” encapsulates its mission to alleviate pain and anxiety in patients undergoing medical procedures.
Their flagship product, Smileyscope VR, stands out as the first regulatory-approved VR device for medical use, demonstrating significant impact in reducing the need for restraints and sedation. This application is praised not only by satisfied clinicians but also by grateful patients and their families. It's used across multiple regions, including Australia, USA, UAE, Europe, and the UK, with adoption in leading hospitals.
In its recent funding journey, Smileyscope secured a Seed Round investment on 03 October 2023. The round was backed by prominent investors such as Brisbane Angels, Breakthrough Victoria, TEN13, and others, showcasing strong confidence in the company's growth trajectory and dedication to expanding patient-centered care.
-logo.jpg){kind=logo}
